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allele. The visceral fat area measured by computerised tomography scan was greater in homozygous Arg 64 Arg (172 ± 17 cm 2 , n = 6) and heterozygous Trp 64 Arg (178 ± 47 cm 2 , n = 48) women than in women homozygous for the Trp 64 Trp (121 ± 46 cm 2 , n = 77) genotype (p < 0.01). This was also reflected by increased total body fat but not by increased body mass index. The association between the Trp 64 allele and visceral fat mass by multiple regression analysis, was independent of age, body mass index and total fat mass (p < 0.004). Moreover, homozygous carriers of the Arg 64 allele had higher systolic blood pressure, higher fasting and post-load glucose and insulin concentrations, higher cholesterol, and triglyceride and lower HDL-cholesterol concentrations than homozygous carriers of the Trp 64 allele. Some of these differences were also observed between heterozygous Trp 64 Arg and homozygous Trp 64 Trp genotypes (glucose tolerance, insulin and cholesterol concentration). We conclude that in obese women the b 3 -AR polymorphism may be used as a genetic marker for visceral fat obesity and the insulin resistance syndrome. [Diabetologia (1997) increase in visceral fat with long-term overfeeding. The b 3 -adrenergic-receptor (b 3 -AR) is mainly expressed in visceral adipose tissue [13] and is considered responsible for lipolysis and delivery of non-esterified fatty acid into the portal vein [14] . Recently, Pima Indians were found to have a high frequency of the Arg 64 allele, and those with the mutation to have an early onset of non-insulin-dependent diabetes mellitus (NIDDM) and a tendency to have a low metabolic rate [15] . This mutation is also associated with an increased capacity to gain weight [16] , and difficulty in losing weight [17] . Widé n et al. [18] reported that this mutation is associated with abdominal obesity and resistance to insulin by waist-to-hip ratio (WHR), which is an indirect measurement of visceral fat. However, WHR does not accurately measure visceral fat mass [19] . The measurement of visceral fat mass by computerised tomographic (CT) scanning is the gold standard for quantitation of visceral obesity. Therefore, in this study, we investigated the association between b 3 -AR polymorphism, visceral fat mass measured by CT scanning and features of the insulin resistance syndrome in obese women.
Subjects and methods
We studied 131 premenopausal obese women (mean age: 38.5 ± 11.8 years; mean duration of obesity: 4.6 ± 1.7 years; mean body weight: 80.6 ± 14.6 kg; mean body mass index 33.3 ± 3.7 kg/m 2 ) who came to the out-patient clinic of our university hospital for treatment of their condition. We also examined 256 age-matched non-obese women (mean age: 35.8 ± 4.4 years; mean body weight 50.5 ± 5.3 kg; mean body mass index 22.3 ± 2.8 kg/m 2 ). All protocols were approved by the University Review Board of Kyoto Prefectural University of Medicine. Written informed consent was obtained from all subjects before enrollment in the study. In obese subjects the proportion of body fat (% body fat) was estimated from skin fold measurements, according to the method of Durnin and Womersley [20] and the body fat distribution was determined by CT scanning according to the procedure of Tokunaga et al. [21] . In obese and non-obese control subjects blood samples were drawn after an overnight fast. Blood glucose was measured by the glucose oxidase method, and serum total cholesterol and triglyceride levels were determined by enzymatic methods. HDL-cholesterol was measured by the heparin-calcium precipitation method. In obese subjects, the 75 g oral glucose tolerance test was also performed, and blood samples were collected at 0, 30, 60, 90, and 120 min to determine glucose and insulin levels. Serum insulin was assayed by double antibody radioimmunoassay. The blood glucose or serum insulin area was determined by the trapezoidal rules [18] . In 98 obese women (not 131) the resting metabolic rate (RMR) was measured by a closed-circuit indirect calorimeter (SanbornWedge type spirometer: metabograph, Model SS-80; Fukuda Medical Laboratory Co., Tokyo, Japan) with a mouth piece, in a temperature-controlled room (22-24°C) after overnight fast [22] . The RMR was obtained as the mean of a 30-min measurement period, and was adjusted [23] by age and lean body mass, which was calculated by subtracting body fat from body weight.
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Statistical analysis
All data are shown as mean ± SD. Differences in continuous variables between obese women and control subjects carrying the Arg/Arg, Trp/Arg or Trp/Trp genotype were tested by Mann-Whitney U-test. When necessary, Bonferroni t-test was performed after justification by one-way ANOVA. In obese subjects, a multiple regression analysis controlled for age, body mass index, percentage of body fat, fasting blood glucose and fasting serum insulin (explanatory variables) was performed to evaluate the impact of polymorphism of the b 3 -AR gene (explanatory variable) on visceral fat mass (response variable). The statistical package of Social Science for Windows, version 6.01, was used for statistical analysis.
Results
There was no difference between the obese women and the non-obese control subjects (0.23 vs 0.17, p = 0.112) in the frequency of the Trp 64 Arg allele (Table 1). In univariate analysis of obese subjects as shown in Table 2 , those with the mutation had an increased percentage of body fat (p < 0.024, Arg/Arg; p < 0.012, Trp/Arg), higher total fat area by CT scanning (p < 0.039, Trp/Arg), higher visceral fat mass (p < 0.006, Arg/Arg; p < 0.001, Trp/Arg), higher systolic blood pressure (p < 0.011, Arg/Arg), higher fasting blood glucose (p < 0.002, Arg/Arg), increased blood glucose area under the curve (p < 0.005, Arg/ Arg; p < 0.001, Trp/Arg), higher fasting serum insulin level (p < 0.003, Arg/Arg; p < 0.001, Trp/Arg), increased insulin area under the curve (p < 0.031, Arg/ Arg; p < 0.001, Trp/Arg), higher total cholesterol (p < 0.008, Arg/Arg; p < 0.021, Trp/Arg), higher triglyceride (p < 0.002, Arg/Arg) and lower HDL cholesterol (p < 0.010, Arg/Arg), compared to those without the mutation, although there was no difference in body mass index or diastolic blood pressure. Furthermore, the adjusted RMR, that was measured in 98 obese women (not 131), was lower in those with the mutation (p < 0.042, Arg/Arg [n = 4; 20 ± 104 kcal/day]; p < 0.022, Trp/Arg [n = 36; 118 ± 131 kcal/ day]) than in those without the mutation (n = 58; 227 ± 227 kcal/day). However, there was no difference in body mass index, blood pressure, blood glucose or serum lipids in control subjects (Table 3) with or without the mutation of the b 3 -AR gene by both Mann-Whitney U-test and Bonferroni t-test.
When adjustments were made for age, body mass index, percentage of body fat, fasting blood glucose and fasting serum insulin in a multiple regression analysis, a significantly positive association was found Arg allele of the b 3 -AR gene and visceral fat mass (p < 0.004).
Discussion
Mutation of the b 3 -AR gene was present with an allelic frequency of 0.23 in Japanese obese women and 0.17 in non-obese control subjects. These values were similar to those reported previously [17, 24, 25] , which was higher than that in black and white Americans [15] , French [16] , Finns [18] , Swedish [26] and Danes [27] but not Pima Indians [15] . These findings suggest that this mutation may play an important role in the Pima Indians and Japanese.
Univariate analysis of the obese women revealed an increase of visceral fat mass, and the characteristics of the insulin resistance syndrome in those with this mutation, i. e. an increased systolic blood pressure, higher fasting blood glucose, increased blood glucose area under the curve, higher fasting serum insulin, increased insulin area under the curve, higher serum total cholesterol, higher serum triglyceride, and decreased serum HDL cholesterol, compared with those without the mutation; although, in non-obese control subjects with and without the mutation of the b 3 -AR gene we could not find any difference in clinical and laboratory data. Kadowaki et al. [24] and Fujisawa et al. [25] both reported higher body mass index among Japanese subjects homozygous for the Trp 64 Arg mutation than those heterozygous and those without the mutation. In this study there was no significant difference between body mass index values and the mutation in either obese or non-obese subjects, although obese women with the mutation had an increased percentage of body fat compared to those without the mutation. The reason for the difference between the present findings and those reported previously is unclear, the gender difference (present, female; Kadowaki [24] , male; Fujisawa [25] , not shown) and the difference in degree of obesity in the subjects (present, obese body mass index (mean) 33.3 kg/m 2 , control 22.3; Kadowaki [24] , 24.7-22.1; Fujisawa [25] , 22.8) may explain this discrepancy. The present result showing the higher visceral fat mass (Arg/Arg, p < 0.006; Trp/Arg p < 0.001) in obese subjects with the b 3 -AR mutation is consistent with our previous finding (Trp/Arg, p < 0.01) with 88 obese women in another study [17] and is in agreement with the result in Finns [18] showing that women with a mutation had a higher WHR (p < 0.008). A larger visceral fat mass is a factor usually accompanied by the insulin resistance syndrome [10] ; therefore, it is not surprising that in the present study obese subjects with the mutation have the features of the insulin resistance syndrome. Indeed, the findings showing an increased systolic blood pressure in obese subjects homozygous for the Trp 64 Arg mutation is in analogy with the weak trend toward higher systolic blood pressure in subjects with the mutant allele reported by Kadowaki et al. [24] . The higher fasting blood glucose (Arg/Arg) and the increased glucose area under the curve (Arg/Arg, Trp/ Arg) in obese subjects found in the present study, have previously been found to be more common among Finns [18] , Pima Indians [15] and Japanese with NIDDM [25] . Kadowaki et al. [24] also reported an increased fasting serum insulin (Arg/Arg; Trp/ Arg) and area under the curve (Arg/Arg; Trp/Arg) in obese subjects homozygous for the mutation as compared to those heterozygous and those without the mutation. The increased total cholesterol (Arg/ Arg; Trp/Arg), increased fasting triglyceride (Arg/ Arg) and decreased HDL cholesterol (Arg/Arg) in obese subjects with the mutation are in contrast with the findings of Kadowaki et al. [24] who did not find any differences in the prevalence of dyslipidaemia between the different alleles, but are in analogy with those reported in young Danes [27] . The discrepancy between our findings and the data of Kadowaki et al. [24] may again be explained by the difference in the degree of obesity in each study. Concerning the RMR, in the present study, we could measure it in only 98 obese women of the total 131. The finding showed that those with the mutation (Arg/Arg; Trp/ Arg) had a lower adjusted RMR, as compared to those without the mutation, being consistent with our previous finding in 88 obese women in another study [17] and is in agreement with the findings in Pima Indians [15] .
Multivariate analysis showed that visceral fat mass among the Trp 64 Arg allele of b 3 -AR gene was independent of body mass index and percentage of body fat. Thus, the polymorphism in its homozygous and heterozygous forms may itself increase the visceral fat mass, because there is more b 3 -AR in visceral fat than in subcutaneous fat [13] . The underlying mechanisms may involve impaired lipolysis [14] , with an associated enlargement of the adipose cells and thereby relative visceral obesity, which may lead to insulin resistance and hyperinsulinism. The latter may cause down-regulation of b 3 -AR, which will promote further progression of obesity and establish a vicious circle, although there are reports showing that when a heterologous system of this mutation was expressed in CHO cells, its mutant receptor was pharmacologically and functionally indistinguishable from the wild type b 3 -AR [28] and that there was no difference in b 3 -AR function between Trp
64
Arg heterozygotes and Trp 64 homozygotes [29] . Although the physiological relevance of b 3 -AR in humans remains to be clarified, pharmacological studies on b 3 -AR agonists in obese subjects have revealed a decrease in their insulin resistance [29] .
The effect of b 3 -AR polymorphism seems to be smaller than was initially expected. However, judging from our present findings and those obtained in the Pima Indians, ethnic differences in the importance of the mutation must be considered. Essentially, this mutation may represent a real "thrifty gene" [30] in the Pima Indians and Japanese.
In conclusion, the Trp
Arg allele is associated with visceral fat obesity and features of the insulin resistance syndrome. Therefore, our findings suggest that the b 3 -AR polymorphism may be used as a genetic marker for visceral fat obesity and the insulin resistance syndrome in obese subjects. Since only six homozygotes were identified among 131 obese women, the results must be interpreted with caution. Further studies using larger population samples will be required.
